For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
You do the crime you bear the publicity - especially if you’re a pharmacist
+News
You do the crime you bear the publicity - especially if you’re a pharmacist
Friday 2 July 2021, 03:30 PM

Fifty-one cases involving pharmacists have been heard by the Health Practitioners Disciplinary Tribunal since it was set up in 2004
Appearing before the Health Practitioners Disciplinary Tribunal is nerve-wracking enough, but for the vast majority of pharmacists who appear, their name will be publicly connected to their misdemeanours for the rest of their careers. Yet, a new study shows this is not the case for other health professionals. Ruth Brown and Steve Hart report
Being publicly named will follow a health practitioner for the rest of their career, long after they have learned from their mistakes
If you wer
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.